Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.60 |
| ▸ | RAB9A | P51151 | 5/20 | 0.60 |
| ▸ | MEN1 | O00255 | 11/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.58 |
| ▸ | MAPT | P10636 | 8/20 | 0.58 |
| ▸ | APEX1 | P27695 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | MYOC | Q99972 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 4/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nicarbazin SCHEMBL578675 | 0.80 | MEN1 (0.66) | NPC1RAB9AMEN1KMT2AMAPT | |
| SCHEMBL8371944 | 0.80 | MEN1 (0.66) | NPC1RAB9AMEN1KMT2AMAPT | |
| Diphenylurea SCHEMBL7539414 | 0.76 | NPC1 (0.62) | NPC1RAB9AMEN1KMT2AMAPT | |
| SCHEMBL1177730 | 0.76 | MEN1 (1.00) | NPC1RAB9AMEN1KMT2AMAPT | |
| SCHEMBL6302157 | 0.76 | MEN1 (1.00) | NPC1RAB9AMEN1KMT2AMAPT | |
| SCHEMBL4115432 | 0.75 | MEN1 (0.82) | NPC1RAB9AMEN1KMT2AMAPT | |
| SCHEMBL24430196 | 0.74 | KMT2A (1.00) | NPC1RAB9AMEN1KMT2AMAPT | |
| SCHEMBL6302417 | 0.71 | MEN1 (0.89) | NPC1RAB9AMEN1KMT2AMAPT | |
| SCHEMBL6302158 | 0.70 | MEN1 (0.68) | NPC1RAB9AMEN1KMT2AMAPT | |
| SCHEMBL3460442 | 0.70 | MEN1 (0.79) | NPC1RAB9AMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119361720-B | Catalyst and preparation method and application thereof | 东风汽车集团股份有限公司 | 2026-05-22 | — | — | CN | claimed |
| US-12606923-B2 | Acid-free pyrolytic synthesis of M-N-C catalyst | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-04-21 | — | — | US | claimed |
| CN-119970999-A | High-activity anticoccidial nicarbazin composition and preparation method thereof | 郑州福源动物药业有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-116474816-B | Fe-N-C ultralow-temperature SCR denitration catalyst and preparation method and application thereof | 山西大学 | 2025-05-02 | — | — | CN | claimed |
| CN-115501273-B | Application of traditional Chinese medicine compound effective extract in preparation of medicine for resisting eimeria tenella | 广西大学 | 2025-03-25 | — | — | CN | claimed |
| CN-119510631-A | Method for detecting anticoccidial drug in poultry products by liquid-mass spectrometry | 东营市疾病预防控制中心 | 2025-02-25 | — | — | CN | claimed |
| CN-119361720-A | Catalyst and preparation method and application thereof | 东风汽车集团股份有限公司 | 2025-01-24 | — | — | CN | claimed |
| US-12201666-B2 | Combination, composition, and method of administering the combination or composition to animals | PHIBRO ANIMAL HEALTH CORPORATION (US) | 2025-01-21 | — | — | US | claimed |
| CN-118873624-A | Veterinary medicine for preventing and treating chicken coccidiosis and preparation method thereof | 重庆市畜牧科学院 | 2024-11-01 | — | — | CN | claimed |
| EP-4440329-A1 | RAW-FIBER CRUSTED PELLETS, FEEDSTUFF CONTAINING THEM, AND CORRESPONDING METHODS AND USES | Farmerscent GmbH (DE) | 2024-10-09 | — | — | EP | claimed |
| US-4665100-A | REDUCTION OF CARRYOVER TO SUBSEQUENT LOTS | ELI LILLY AND COMPANY (US) | 1987-05-12 | — | — | US | claimed |
| EP-0217631-A2 | Nicarbazin feed premix | ELI LILLY AND COMPANY (US) | 1987-04-08 | — | — | EP | claimed |
| EP-0209971-A1 | Polyether antibiotic and process for its production | ELI LILLY AND COMPANY (US) | 1987-01-28 | — | — | EP | claimed |
| EP-0184291-A2 | Polyether antibiotic A80190 | ELI LILLY AND COMPANY (US) | 1986-06-11 | — | — | EP | claimed |
| EP-0182117-A1 | Anticoccidial compostions | AMERICAN CYANAMID COMPANY (US) | 1986-05-28 | — | — | EP | claimed |
| US-4582822-A | ANIMAL FEED ADDITIVES | ELI LILLY AND COMPANY (US) | 1986-04-15 | — | — | US | claimed |
| EP-0015110-B1 | ANTICOCCIDIAL COMPOSITION, CARBANILIDES AND METHOD OF PREPARING THEM | ELI LILLY AND COMPANY (US) | 1985-08-21 | — | — | EP | claimed |
| EP-0060680-A1 | Process for formulating a medicated animal feed premix | ELI LILLY AND COMPANY (US) | 1982-09-22 | — | — | EP | claimed |
| EP-0015110-A2 | Anticoccidial composition, carbanilides and method of preparing them | ELI LILLY AND COMPANY (US) | 1980-09-03 | — | — | EP | claimed |
| US-4218438-A | POULTRY FEED | ELI LILLY AND COMPANY (US) | 1980-08-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606923-B2 | Acid-free pyrolytic synthesis of M-N-C catalyst | LMNA, MNS1, FLNB | NPC1 1418/4885RAB9A 1022/4885MEN1 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.